Life Sciences Archives - Page 28 of 33 - Boston Life Sciences Times

Vyome Appoints Dr. Aditya Bardia as Senior Medical Advisor to Guide Development of MFW Program

November 25, 2025

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

November 14, 2025

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

November 13, 2025

THIS WEEK'S STORIES

Sarepta Updates Clinical Progress for SRP-1003 in Myotonic Dystrophy Type 1

November 24, 2025

Galux Reports AI Engine Produced High-Affinity Antibodies From Only 50 Designs

November 26, 2025

Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence

November 25, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences

Life Sciences and Investment Leaders at BioFuture 2025 Signal Renewed Optimism in Health and Biotech Sectors

ONDEX Automation Acquires PlantOPS Consulting to Expand Life Sciences Capabilities

Gut Neurons Decoded: New Study Reveals How Food Allergies and Microbes Rewire the Gut’s Nervous System

ASU’s New School of Medicine Receives Preliminary Accreditation, Major Gift, and New Name

Loomis Sayles Partners with ICE Climate to Enhance Global Climate Risk Analysis

Most Read

GE HealthCare Receives FDA Authorization for Deep-Learning Mammography Reconstruction Tool

Otsuka’s VOYXACT Wins FDA Accelerated Approval for IgA Nephropathy Proteinuria Reduction

Galux Reports AI Engine Produced High-Affinity Antibodies From Only 50 Designs

EdgeOne Medical Hires Industry Veteran Marty Shelton as Chief Operating Officer

EDITOR PICKS

Vyome Appoints Dr. Aditya Bardia as Senior Medical Advisor to Guide Development of MFW Program

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

THIS WEEK'S STORIES

Sarepta Updates Clinical Progress for SRP-1003 in Myotonic Dystrophy Type 1

Galux Reports AI Engine Produced High-Affinity Antibodies From Only 50 Designs

Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence

POPULAR CATEGORY

ABOUT US

FOLLOW US